College of Pharmacy and International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education, Jinan University, Guangzhou 510632, China.
NMPA Key Laboratory for Bioequivalence Research of Generic Drug Evaluation, Shenzhen Institute for Drug Control, Shenzhen 518057, China.
Int J Mol Sci. 2024 Oct 17;25(20):11171. doi: 10.3390/ijms252011171.
The kidney, an essential excretory organ of the body, performs a series of crucial physiological functions such as waste removal, maintenance of electrolyte and acid-base balance, and endocrine regulation. Due to its rich blood flow and high metabolic activity, the kidney is susceptible to damage. Currently, kidney injury is classified into acute kidney injury (AKI) and chronic kidney disease (CKD), both of which are associated with high rates of morbidity and mortality on a global scale. The current clinical diagnosis of renal injury relies on the assessment of renal filtration function using creatinine and urea nitrogen as "gold-standard" markers. However, the delayed response time, limited specificity, and reduced accuracy of creatinine and urea nitrogen in evaluating kidney injury have significantly hindered advancements in diagnostic methods for kidney injury. Urinary protein is widely utilized as a biomarker for the early diagnosis of kidney injury due to the selectivity of the glomerular filtration system determining whether proteins can pass through the filtration barrier based on their size and charge. Therefore, as a complex biological sample with varying charges and particle sizes, urinary protein is considered an ideal indicator for monitoring the progression of kidney disease. Exploring the relationship between urinary protein and the advancement of kidney injury based on differences in particle size and charge offers a new perspective for assessing and treating such injuries. Hence, we conducted a comprehensive review of 74 relevant studies to gain a thorough understanding of the physiological mechanism and significance of proteinuria production. The aim was to explore the challenges and opportunities in clinical urine protein detection, as well as to discuss strategies targeting glomerular filtration barriers in order to effectively reduce urine protein levels and treat kidney injury, which could provide a new perspective for identifying the progression of kidney injury.
肾脏是人体重要的排泄器官,具有多种关键的生理功能,如清除废物、维持电解质和酸碱平衡以及内分泌调节。由于其丰富的血液供应和高代谢活性,肾脏容易受到损伤。目前,肾脏损伤分为急性肾损伤(AKI)和慢性肾脏病(CKD),这两种疾病在全球范围内都具有较高的发病率和死亡率。目前,临床诊断肾脏损伤依赖于肌酐和尿素氮等“金标准”标志物评估肾脏滤过功能。然而,肌酐和尿素氮在评估肾脏损伤时反应时间延迟、特异性有限且准确性降低,这极大地阻碍了肾脏损伤诊断方法的发展。由于肾小球滤过系统的选择性,根据蛋白质的大小和电荷决定其是否能通过滤过屏障,因此尿蛋白被广泛用作肾脏损伤早期诊断的生物标志物。因此,作为一种具有不同电荷和粒径的复杂生物样本,尿蛋白被认为是监测肾脏疾病进展的理想指标。基于粒径和电荷的差异探讨尿蛋白与肾脏损伤进展的关系,为评估和治疗此类损伤提供了新的视角。因此,我们对 74 项相关研究进行了全面综述,以深入了解蛋白尿产生的生理机制和意义。目的是探讨临床尿蛋白检测的挑战和机遇,以及针对肾小球滤过屏障的治疗策略,以有效降低尿蛋白水平并治疗肾脏损伤,为识别肾脏损伤进展提供新视角。